Results 21 to 30 of about 550,806 (288)
IX Forum on Translational Immunology and Cancer Immuno-therapy (FIT Cancer 9)
OncoImmunology, 2023 /INTRODUCTIONTumor immunology and cancer immunotherapy is a growing field, continuously evolving. Different types of immunotherapies have been implemented over last decade in the standard of care across several tumor types.
doaj +1 more source
Immunology and immunotherapy in breast cancer
Cancer Biology & Medicine, 2022 Immuno-oncology is a rapidly developing field in medicine. Drug combination therapies have already been studied in many clinical trials on various tumor types. In recent years, a checkpoint inhibition therapy with monoclonal antibodies targeting PD-1 and
Vladimir Semiglazov +5 more
doaj +1 more source
Special Issue: Cancer Metastasis and Therapeutic Resistance
Biomedicines, 2023 Metastasis and resistance to cancer therapeutics are critical barriers to curing cancer. This special issue entitled “Cancer Metastasis and Therapeutic Resistance” contains nine original contributions.
Elizabeth S. Yeh
doaj +1 more source
Altered expression of caspases-4 and -5 during inflammatory bowel disease and colorectal cancer : diagnostic and therapeutic potential [PDF]
, 2015 Caspases are a group of proteolytic enzymes involved in the co-ordination of cellular processes, including cellular homeostasis, inflammation and apoptosis.
Caiazza, F +12 more
core +2 more sources
Moleculer nutritional immunology and cancer
Journal of Oncological Sciences, 2018 The immune system composed of cells that are sensitive to a series of surrounding factors and forming an integrated network. During the last decade a significant increase in the number of studies demonstrated that diet components released from adipocytes
Rüksan Çehreli
doaj +1 more source
Nature Communications, 2023 There is significant clinical interest in targeting adenosine-mediated immunosuppression, with several small molecule inhibitors having been developed for targeting the A2AR receptor.
Kirsten L. Todd +26 more
doaj +1 more source
JTM’s Tumor immunology goes broad: announcing the Immunobiology and Immunotherapy section
Journal of Translational Medicine, 2013 For the last four years the Journal of Translational Medicine (JTM) has hosted the Section of Tumor Immunology and Biological Cancer Therapy. Under the editorial leadership of Dr.
Bot Adrian +2 more
doaj +1 more source
Gastric cancer is the leading cause of death in Italian adult patients with common variable immunodeficiency [PDF]
, 2018 An increased prevalence of malignant lymphoma and of gastric cancer has been observed in large cohorts of patients with common variable immunodeficiency (CVID), the most frequently symptomatic primary immunodeficiency. Surveillance strategies for cancers
Agostini, Carlo +11 more
core +3 more sources
Nano-Enhanced Cancer Immunotherapy: Immunology Encounters Nanotechnology
Cells, 2020 Cancer immunotherapy utilizes the immune system to fight cancer and has already moved from the laboratory to clinical application. However, and despite excellent therapeutic outcomes in some hematological and solid cancers, the regular clinical use of ...
Ernesto Bockamp +3 more
doaj +1 more source
Exploiting the neoantigen landscape for immunotherapy of pancreatic ductal adenocarcinoma [PDF]
, 2016 Immunotherapy approaches for pancreatic ductal adenocarcinoma (PDAC) have met with limited success. It has been postulated that a low mutation load may lead to a paucity of T cells within the tumor microenvironment (TME).
Alvarez, Hector A. +13 more
core +1 more source